Elfie for US Life Insurance

An Evidence-Backed Engagement Layer Within the Real Constraints of Life Insurance

Elfie is an evidence-backed health engagement and medication-adherence platform designed to integrate into U.S. group and individual life insurance ecosystems. It is not a pricing mechanism, inducement program or underwriting shortcut. It is a voluntary engagement layer engineered to measurably improve chronic condition control and treatment adherence while strengthening persistency, employer value perception, policyholder trust and long-term customer lifetime value.

Over two decades, U.S. life insurers have experimented with wellness, incentives and engagement platforms. The lessons are clear: short-term mortality improvement is unrealistic in insured populations (Swiss Re Institute, 2022; Munich Re, 2021). Engagement value accrues first through persistency, satisfaction and trust — not immediate claims reduction (OECD, 2022; Business Group on Health, 2023). Programs that blurred engagement with pricing or underwriting frequently encountered regulatory resistance and reputational risk. Programs that preserved voluntariness and separation from insurance mechanics proved more durable.

Elfie is designed explicitly within those historical constraints.

US Group Life Insurance: Applying Behavioral Science With Regulatory Discipline

Activation: Lowering Friction Without Creating Inducement Risk

In group life, enrollment is typically automatic and pricing is employer-level. Employees often have limited awareness of the benefit. The first engagement challenge is activation.

Behavioral science shows that action occurs when motivation, ability and prompts align (Fogg, 2009). In group life, motivation is often low; friction must therefore be minimal. However, regulatory risk increases if incentives resemble premium inducements or outcome-based differentiation (OECD, 2022).

Elfie addresses this by making engagement fully voluntary, modular and user-directed. Members choose what to explore, what to monitor and whether to connect data sources. No participation is mandated. No benefit differentiation is tied to outcomes. This structure reduces inducement risk and preserves employer comfort.

Insurer risk consideration: Over-engineering onboarding, layering excessive gamification or implying underwriting linkage would reintroduce inducement and fairness concerns. Configuration discipline is therefore essential.

Early Engagement: Building Capability and Opportunity at the User’s Pace

After activation, sustained engagement requires capability, opportunity and reinforcement (Michie, van Stralen and West, 2011). Many legacy programs failed here by assuming early interest would sustain itself, while increasing cognitive load through fragmented portals and static rewards.

Elfie grows engagement gradually. Users control pacing. Some begin with activity tracking; others focus on stress or medication support. Insights deepen only as engagement deepens. This protects autonomy and reduces overload.

For group life carriers, this pacing matters. Introducing condition-specific or clinical features too early can create relevance concerns among generally healthy employees. The system therefore allows progression rather than prescription.

Insurer risk consideration: Engagement must not inadvertently segment populations in ways that raise perceived fairness issues. Voluntary progression mitigates this exposure.

Sustained Engagement: Transitioning From Extrinsic to Intrinsic Motivation

Long-term behavior depends primarily on intrinsic motivation — autonomy, competence and personal relevance (Ryan and Deci, 2000; Ryan and Deci, 2017). However, extrinsic reinforcement can effectively scaffold early behavior (Hamari, Koivisto and Sarsa, 2014; Sardi, Idri and Fernández-Alemán, 2017).

Neuroscience explains why structured gamification can remain sustainable when designed correctly. Chronic disease management involves behaviors whose benefits are delayed and abstract — a classic case of temporal discounting (Frederick, Loewenstein and O’Donoghue, 2002). The brain undervalues distant health gains. Small, immediate feedback signals — visible progress markers, streaks, milestones — activate reward prediction pathways that reinforce repetition. These “small wins” help convert intention into habit without requiring large financial incentives.

The distinction is critical. Sustainable gamification is not about large payouts or aggressive rewards; those structures risk gaming, distrust and regulatory scrutiny. Instead, frequent, meaningful feedback makes invisible health effort visible. Over time, competence increases and intrinsic motivation strengthens.

Elfie uses extrinsic cues as scaffolding and re-engagement tools, not as permanent drivers. As insight deepens and routines stabilize, motivation shifts toward internal relevance.

Insurer risk consideration: Heavy financial incentives tied to health metrics can trigger inducement scrutiny in group life and fairness concerns in individual life. Elfie’s light-touch reinforcement structure avoids this exposure.

Multi-Year Engagement: Trust, Continuity and Employer Value

At multi-year horizons, the strongest group life programs became embedded within employer benefit ecosystems. Their value lay in reinforcing trust and continuity rather than driving discrete behaviors (Munich Re, 2021).

Elfie’s autonomy-first architecture becomes strategically important here. Because it does not depend on premium discounts or outcome-based differentiation, it avoids the structural risks that constrained earlier programs. Data remains user-controlled and engagement-focused.

The trade-off is candid: engagement programs optimized for trust and durability do not generate immediate mortality ROI narratives. Signals accumulate gradually and unevenly across populations. However, history suggests that attempts to accelerate ROI through pricing linkage often undermined long-term sustainability.

Insurer risk consideration: Executive expectations must align with realistic time horizons. Engagement should be positioned as persistency and relevance infrastructure, not as a near-term claims lever.

Clinical Evidence: Moving Beyond Engagement Theory

Elfie is not solely behaviorally grounded; it now has platform-specific clinical evidence.

In a real-world evidence analysis involving 22,901 individuals with hypertension using the Elfie self-monitoring and gamified mobile health application, statistically significant improvements were observed over 12 months (Berwanger et al., 2026). Blood pressure control increased from 34.4% at one month to 51.6% at 12 months. Mean systolic blood pressure decreased by 9.5 mmHg and diastolic pressure by 6.3 mmHg (p≤0.001). Self-reported medication adherence improved from 33.9% to 50.8%.

In addition, the ELFIE-HYPERTENSION pragmatic randomized controlled trial has been designed to evaluate six-month changes in systolic blood pressure compared with usual care (Martins et al., 2026). This strengthens the evidence base beyond observational findings.

For life insurers, this distinction matters. Elfie does not claim immediate mortality reduction. It demonstrates measurable intermediate cardiometabolic improvements — particularly blood pressure control and adherence — that are epidemiologically linked to long-term cardiovascular risk reduction. This aligns with actuarial reality rather than overstating impact.

Governance, Underwriting and Regulatory Boundaries

In group life, risk emerges when engagement links to premium differentiation, mandates participation or collects data beyond informed consent (OECD, 2022). In individual life, risk shifts toward perceived discrimination, opacity and trust erosion.

Elfie’s modular architecture supports:

• Voluntary participation
• Clear separation from underwriting processes
• Transparent data use
• User-controlled data sharing

This separation is not cosmetic; it is structural. Engagement remains relationship infrastructure, not a silent underwriting funnel.

Key insurer concerns addressed:

• Mortality impact overstatement: Not claimed.
• Inducement risk: Avoided through voluntary, non-premium-linked design.
• Data misuse perception: Mitigated via user control and transparency.
• Actuarial ROI timing: Positioned as long-horizon engagement and persistency infrastructure.
• Reputational risk: Reduced through autonomy-first architecture.

Strategic Synthesis

Elfie reflects the maturation of life insurance engagement design. It applies behavioral science sequentially, respects regulatory constraints as design parameters, and grounds its cardiometabolic focus in measurable intermediate outcomes rather than speculative mortality claims.

For U.S. group life carriers, it enhances employer value perception and member relevance without creating inducement or pricing exposure.
For individual life carriers, it supports activation, lapse reduction and trust continuity without transforming engagement into covert underwriting.

Used thoughtfully, Elfie is not a mortality lever. It is behavioral relationship infrastructure — engineered for durability, regulatory defensibility and measurable cardiometabolic improvement within the economic and legal realities of U.S. life insurance.

Join us for an upcoming LinkedIn live on the future of engagement in life insurance.

References 

Berwanger, O. et al. (2026) ‘Blood pressure control in patients using the Elfie self-monitoring and gamified mobile health application: a real-world evidence study involving over 22,000 users’, European Heart Journal – Digital Health, 7(Supplement_1), ztaf143.081.

Business Group on Health (2023) Large Employers’ Health Care Strategy Survey.

Fogg, B.J. (2009) ‘A behavior model for persuasive design’, Proceedings of the International Conference on Persuasive Technology.

Frederick, S., Loewenstein, G. and O’Donoghue, T. (2002) ‘Time discounting and time preference: A critical review’, Journal of Economic Literature, 40(2), pp. 351–401.

Hamari, J., Koivisto, J. and Sarsa, H. (2014) ‘Does gamification work? A literature review of empirical studies on gamification’, HICSS Proceedings, pp. 3025–3034.

Martins, E. et al. (2026) ‘Rationale and design of a pragmatic randomized clinical trial assessing a smartphone-based digital health intervention in hypertension: The ELFIE-HYPERTENSION trial’, American Heart Journal, 107380.

Michie, S., van Stralen, M.M. and West, R. (2011) ‘The behaviour change wheel’, Implementation Science, 6, p. 42.

Munich Re (2021) Behavioral Risk and Longevity.

OECD (2022) Health in the 21st Century.

Ryan, R.M. and Deci, E.L. (2000) ‘Intrinsic and extrinsic motivations’, Contemporary Educational Psychology, 25(1), pp. 54–67.

Ryan, R.M. and Deci, E.L. (2017) Self-Determination Theory. New York: Guilford Press.

Sardi, L., Idri, A. and Fernández-Alemán, J.L. (2017) ‘A systematic review of gamification in e-health’, Journal of Biomedical Informatics, 71, pp. 31–48.

Swiss Re Institute (2022) Preventing Chronic Diseases.